218 related articles for article (PubMed ID: 29182983)
1. Mammospheres of hormonal receptor positive breast cancer diverge to triple-negative phenotype.
Laranjo M; Carvalho MJ; Costa T; Alves A; Oliveira RC; Casalta-Lopes J; Cordeiro P; Botas F; Abrantes AM; Paiva A; Oliveira C; Botelho MF
Breast; 2018 Apr; 38():22-29. PubMed ID: 29182983
[TBL] [Abstract][Full Text] [Related]
2. Endometrial Cancer Spheres Show Cancer Stem Cells Phenotype and Preference for Oxidative Metabolism.
Carvalho MJ; Laranjo M; Abrantes AM; Casalta-Lopes J; Sarmento-Santos D; Costa T; Serambeque B; Almeida N; Gonçalves T; Mamede C; Encarnação J; Oliveira R; Paiva A; de Carvalho R; Botelho F; Oliveira C
Pathol Oncol Res; 2019 Jul; 25(3):1163-1174. PubMed ID: 30499076
[TBL] [Abstract][Full Text] [Related]
3. Identification of a stemness-related gene panel associated with BET inhibition in triple negative breast cancer.
Serrano-Oviedo L; Nuncia-Cantarero M; Morcillo-Garcia S; Nieto-Jimenez C; Burgos M; Corrales-Sanchez V; Perez-Peña J; Győrffy B; Ocaña A; Galán-Moya EM
Cell Oncol (Dordr); 2020 Jun; 43(3):431-444. PubMed ID: 32166583
[TBL] [Abstract][Full Text] [Related]
4. Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors.
Laranjo M; Carvalho MJ; Serambeque B; Alves A; Marto CM; Silva I; Paiva A; Botelho MF
J Vis Exp; 2020 Mar; (157):. PubMed ID: 32176214
[TBL] [Abstract][Full Text] [Related]
5. Hematogenic Dissemination of Triple-negative Versus Hormonal Receptor-positive Breast Cancer Cells.
Carvalho MJ; Abrantes AM; Laranjo M; Paiva B; Torgal I; Cabrita AS; Botelho F; DE Oliveira CF
In Vivo; 2015; 29(4):435-44. PubMed ID: 26130788
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the stemness potency of
Yousefnia S; Ghaedi K; Seyed Forootan F; Nasr Esfahani MH
Tumour Biol; 2019 Aug; 41(8):1010428319869101. PubMed ID: 31423948
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Sonic Hedgehog Signaling Pathway by Thiazole Antibiotic Thiostrepton Attenuates the CD44+/CD24-Stem-Like Population and Sphere-Forming Capacity in Triple-Negative Breast Cancer.
Yang N; Zhou TC; Lei XX; Wang C; Yan M; Wang ZF; Liu W; Wang J; Ming KH; Wang BC; Xu BL; Liu Q
Cell Physiol Biochem; 2016; 38(3):1157-70. PubMed ID: 26963129
[TBL] [Abstract][Full Text] [Related]
8. [Influence factors on the formation of mammospheres from breast cancer stem cells].
Huang MZ; Zhang FC; Zhang YY
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Oct; 40(5):500-4. PubMed ID: 18931713
[TBL] [Abstract][Full Text] [Related]
9. In vitro analysis of breast cancer cell line tumourspheres and primary human breast epithelia mammospheres demonstrates inter- and intrasphere heterogeneity.
Smart CE; Morrison BJ; Saunus JM; Vargas AC; Keith P; Reid L; Wockner L; Askarian-Amiri M; Sarkar D; Simpson PT; Clarke C; Schmidt CW; Reynolds BA; Lakhani SR; Lopez JA
PLoS One; 2013; 8(6):e64388. PubMed ID: 23750209
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA expression analysis of mammospheres cultured from human breast cancers.
Feifei N; Mingzhi Z; Yanyun Z; Huanle Z; Fang R; Mingzhu H; Mingzhi C; Yafei S; Fengchun Z
J Cancer Res Clin Oncol; 2012 Nov; 138(11):1937-44. PubMed ID: 22752669
[TBL] [Abstract][Full Text] [Related]
11. Modification of topoisomerases in mammospheres derived from breast cancer cell line: clinical implications for combined treatments with tyrosine kinase inhibitors.
Peleg R; Romzova M; Kogan-Zviagin I; Apte RN; Priel E
BMC Cancer; 2014 Dec; 14():910. PubMed ID: 25472619
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic characterization of mammosphere-forming cells from the human MA-11 breast carcinoma cell line.
Rappa G; Lorico A
Exp Cell Res; 2010 May; 316(9):1576-86. PubMed ID: 20074564
[TBL] [Abstract][Full Text] [Related]
13. Mammosphere-derived gene set predicts outcome in patients with ER-positive breast cancer.
Kok M; Koornstra RH; Margarido TC; Fles R; Armstrong NJ; Linn SC; Van't Veer LJ; Weigelt B
J Pathol; 2009 Jul; 218(3):316-26. PubMed ID: 19353633
[TBL] [Abstract][Full Text] [Related]
14. Estrogen Receptor β as a Therapeutic Target in Breast Cancer Stem Cells.
Ma R; Karthik GM; Lövrot J; Haglund F; Rosin G; Katchy A; Zhang X; Viberg L; Frisell J; Williams C; Linder S; Fredriksson I; Hartman J
J Natl Cancer Inst; 2017 Mar; 109(3):1-14. PubMed ID: 28376210
[TBL] [Abstract][Full Text] [Related]
15. The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation.
Phillips TM; McBride WH; Pajonk F
J Natl Cancer Inst; 2006 Dec; 98(24):1777-85. PubMed ID: 17179479
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D compounds reduce mammosphere formation and decrease expression of putative stem cell markers in breast cancer.
Wahler J; So JY; Cheng LC; Maehr H; Uskokovic M; Suh N
J Steroid Biochem Mol Biol; 2015 Apr; 148():148-55. PubMed ID: 25445919
[TBL] [Abstract][Full Text] [Related]
17. Tumor initiating cells: development and critical characterization of a model derived from the A431 carcinoma cell line forming spheres in suspension.
Bortolomai I; Canevari S; Facetti I; De Cecco L; Castellano G; Zacchetti A; Alison MR; Miotti S
Cell Cycle; 2010 Mar; 9(6):1194-206. PubMed ID: 20237414
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional profiles of different states of cancer stem cells in triple-negative breast cancer.
Liu M; Liu Y; Deng L; Wang D; He X; Zhou L; Wicha MS; Bai F; Liu S
Mol Cancer; 2018 Feb; 17(1):65. PubMed ID: 29471829
[TBL] [Abstract][Full Text] [Related]
19. ∆Np63/p40 correlates with the location and phenotype of basal/mesenchymal cancer stem-like cells in human ER
Liu Y; Nekulova M; Nenutil R; Horakova I; Appleyard MV; Murray K; Holcakova J; Galoczova M; Quinlan P; Jordan LB; Purdie CA; Vojtesek B; Thompson AM; Coates PJ
J Pathol Clin Res; 2020 Jan; 6(1):83-93. PubMed ID: 31591823
[TBL] [Abstract][Full Text] [Related]
20. Senescence evasion by MCF-7 human breast tumor-initiating cells.
Karimi-Busheri F; Rasouli-Nia A; Mackey JR; Weinfeld M
Breast Cancer Res; 2010; 12(3):R31. PubMed ID: 20525204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]